DRUG

ofatumumab

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for ofatumumab

Rheumatoid arthritis 1

Mediator Outcome Score Tier Lit. status Trial
CD20 CDAI 0.264 Mid novel signal none

Clinical trials

190 registered trials for ofatumumab

Source: ClinicalTrials.gov

← All drugs